NO960347D0 - Anvendelse av benzydamid ved behandling av patologiske tilstander forårsaket av TNF - Google Patents

Anvendelse av benzydamid ved behandling av patologiske tilstander forårsaket av TNF

Info

Publication number
NO960347D0
NO960347D0 NO960347A NO960347A NO960347D0 NO 960347 D0 NO960347 D0 NO 960347D0 NO 960347 A NO960347 A NO 960347A NO 960347 A NO960347 A NO 960347A NO 960347 D0 NO960347 D0 NO 960347D0
Authority
NO
Norway
Prior art keywords
tnf
treatment
pathological conditions
benzydamide
conditions caused
Prior art date
Application number
NO960347A
Other languages
English (en)
Other versions
NO308195B1 (no
NO960347L (no
Inventor
Valerio Cioli
Original Assignee
Angelini Francesco Ist Ricerca
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angelini Francesco Ist Ricerca filed Critical Angelini Francesco Ist Ricerca
Publication of NO960347D0 publication Critical patent/NO960347D0/no
Publication of NO960347L publication Critical patent/NO960347L/no
Publication of NO308195B1 publication Critical patent/NO308195B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO960347A 1993-07-27 1996-01-26 Anvendelse av benzydamin til fremstilling av et legemiddel ved behandling av patologiske tilstander forÕrsaket av TNF NO308195B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT93MI001673A IT1276040B1 (it) 1993-07-27 1993-07-27 Uso della benzidamina nel trattamento di stati patologici causati dal tnf
PCT/EP1994/002343 WO1995003799A1 (en) 1993-07-27 1994-07-14 Use of benzydamine in the treatment of pathological conditions caused by tnf

Publications (3)

Publication Number Publication Date
NO960347D0 true NO960347D0 (no) 1996-01-26
NO960347L NO960347L (no) 1996-03-07
NO308195B1 NO308195B1 (no) 2000-08-14

Family

ID=11366694

Family Applications (1)

Application Number Title Priority Date Filing Date
NO960347A NO308195B1 (no) 1993-07-27 1996-01-26 Anvendelse av benzydamin til fremstilling av et legemiddel ved behandling av patologiske tilstander forÕrsaket av TNF

Country Status (25)

Country Link
US (1) US6300358B1 (no)
EP (1) EP0711163B1 (no)
JP (1) JP3587851B2 (no)
CN (1) CN1085528C (no)
AT (1) ATE207353T1 (no)
AU (1) AU692458B2 (no)
BG (1) BG62841B1 (no)
CA (1) CA2167926C (no)
CZ (1) CZ285864B6 (no)
DE (1) DE69428797T2 (no)
DK (1) DK0711163T3 (no)
ES (1) ES2163450T3 (no)
HU (1) HU226805B1 (no)
IT (1) IT1276040B1 (no)
LV (1) LV11524B (no)
NO (1) NO308195B1 (no)
NZ (1) NZ269563A (no)
PL (1) PL312741A1 (no)
PT (1) PT711163E (no)
RO (1) RO117149B1 (no)
RU (1) RU2160102C2 (no)
SI (1) SI0711163T1 (no)
SK (1) SK281895B6 (no)
WO (1) WO1995003799A1 (no)
ZA (1) ZA945431B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101199515B (zh) * 2007-12-21 2010-12-08 重庆市莱美药物技术有限公司 盐酸苄达明洗剂及其制备方法
WO2010093588A1 (en) * 2009-02-10 2010-08-19 Celgene Corporation Methods of using and compositions comprising pde4 modulators for treatment, prevention and management of tuberculosis
HUE028220T2 (en) * 2009-07-08 2016-12-28 Acraf The use of benzidamine in the treatment of p40-dependent diseases
MD4291C1 (ro) * 2013-12-27 2015-02-28 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Preparat medicamentos pentru tratamentul otitelor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1054833A (no) * 1963-08-09
US4980160A (en) * 1986-10-16 1990-12-25 Biogen, Inc. Combinations of tumor necrosis factors and anti-inflammatory agents and methods for treating malignant and non-malignant diseases
US5563143A (en) * 1994-09-21 1996-10-08 Pfizer Inc. Catechol diether compounds as inhibitors of TNF release

Also Published As

Publication number Publication date
AU692458B2 (en) 1998-06-11
CZ285864B6 (cs) 1999-11-17
PL312741A1 (en) 1996-05-13
ES2163450T3 (es) 2002-02-01
ITMI931673A0 (it) 1993-07-27
EP0711163A1 (en) 1996-05-15
ZA945431B (en) 1995-02-28
SI0711163T1 (en) 2001-12-31
NZ269563A (en) 2001-03-30
SK10596A3 (en) 1997-03-05
DE69428797D1 (de) 2001-11-29
NO308195B1 (no) 2000-08-14
RO117149B1 (ro) 2001-11-30
BG62841B1 (bg) 2000-09-29
JPH09500385A (ja) 1997-01-14
ATE207353T1 (de) 2001-11-15
LV11524A (lv) 1996-10-20
BG100385A (bg) 1996-09-30
ITMI931673A1 (it) 1995-01-27
IT1276040B1 (it) 1997-10-24
HUT73500A (en) 1996-08-28
AU7386194A (en) 1995-02-28
CN1130872A (zh) 1996-09-11
CA2167926C (en) 2004-12-21
DK0711163T3 (da) 2001-11-26
NO960347L (no) 1996-03-07
SK281895B6 (sk) 2001-09-11
DE69428797T2 (de) 2002-04-18
EP0711163B1 (en) 2001-10-24
CZ25596A3 (en) 1996-07-17
LV11524B (en) 1996-12-20
HU226805B1 (en) 2009-10-28
PT711163E (pt) 2002-04-29
WO1995003799A1 (en) 1995-02-09
CN1085528C (zh) 2002-05-29
CA2167926A1 (en) 1995-02-09
US6300358B1 (en) 2001-10-09
RU2160102C2 (ru) 2000-12-10
JP3587851B2 (ja) 2004-11-10

Similar Documents

Publication Publication Date Title
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
CA2274074A1 (en) Novel compounds with analgesic effect
CA2289717A1 (en) Novel therapy for constipation
EP1029540A3 (en) Use of droloxifene for the treatment of cardiovascular diseases
RO116342B1 (ro) Compoziţie farmaceutică lichidă, orală
IE780643L (en) THERAPEUTIC APPLICATION OF d, 1-CARNITINE DERIVITIVES
DE69331605D1 (de) Verwendung von phenserin zur herstellung von medikamenten zur behandlung von kognitiven störungen
DE69814394D1 (de) Verwendung von levobupivacain
ATE99172T1 (de) Verwendung von acetyl-l-carnitin zur behandlung von katarakt, sowie pharmazeutische zusammensetzungen fuer eine derartige behandlung.
RU94002133A (ru) 6-хлор-5-фтор-3-(2-теноил)-2-оксиндол-1-карбоксамид как аналгезирующее и противовоспалительное средство
TR200000455T2 (tr) Alzheimer hastalığının tedavisinde fankinonun kullanılması.
HUP9902135A2 (hu) (+)-alfa-(2,3-Dimetoxi-fenil)-1-[2-(4-fluor-fenil)-etil]-4-piperidin-metanol alkalmazása depresszív és bipoláris rendellenességek kezelésére alkalmas gyógyszerkészítmény előállítására
NO960347L (no) Anvendelse av benzydamid ved behandling av patologiske tilstander forårsaket av TNF
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
NZ303993A (en) Pharmaceutical compositions containing aminotetralin derivatives for treating cardiac disorders
RU94011321A (ru) Способ профилактики и лечения заболеваний кожи
ZA885590B (en) Pharmaceutical composition intended for the prevention and treatment of bacterial or viral diseases
DE69100171D1 (de) Synergistische kombination zur ophthalmischen verwendung.
DE69300037D1 (de) Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria.
WO1986006960A3 (en) Use of nicorandil or pinacidil for the treatment of peripheral vascular disease
CA2135752A1 (en) Use of (E)-2-(p-Fluorophenethyl)-3-Fluoroallylamine in the Treatment of Alzheimer's Disease
FI953725A (fi) Ornitiiniaminotransferaasi-inhibiittorien käyttö lääkeaineen valmistamiseksi Alzheimerin taudin hoitamiseksi
DE69228235D1 (de) Verwendung eines Mittels zur Herstellung eines Arzneimittels zur Behandlung von Lebererkrankung
CA2341891A1 (en) The use of r(+)-.alpha.-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol for the treatment of sleep disorders
RU96118559A (ru) Лекарственное средство

Legal Events

Date Code Title Description
MK1K Patent expired